BACKGROUND: Impaired lung function is associated with systemic inflammation and is a risk factor for cardiovascular disease in older adults. It is unknown when these associations emerge and to what extent they are mediated by smoking, chronic airways disease, and/or established atherosclerosis. We explored the association between the forced expiratory volume in one second (FEV(1)) and the systemic inflammatory marker C-reactive protein (CRP) in young adults. METHODS: Associations between spirometric lung function and blood CRP were assessed in a population based birth cohort of approximately 1000 New Zealanders at ages 26 and 32 years. Analyses adjusted for height and sex to account for differences in predicted lung function and excluded pregnant women. RESULTS: There were significant inverse associations between FEV(1) and CRP at both ages. Similar results were found for the forced vital capacity. These associations were similar in men and women and were independent of smoking, asthma, and body mass index. CONCLUSIONS: Reduced lung function is associated with systemic inflammation in young adults. This association is not related to smoking, asthma, or obesity. The reasons for the association are unexplained, but the findings indicate that the association between lower lung function and increased inflammation predates the development of either chronic lung disease or clinically significant atherosclerosis. The association between poor lung function and cardiovascular disease may be mediated by an inflammatory mechanism.
BACKGROUND: Impaired lung function is associated with systemic inflammation and is a risk factor for cardiovascular disease in older adults. It is unknown when these associations emerge and to what extent they are mediated by smoking, chronic airways disease, and/or established atherosclerosis. We explored the association between the forced expiratory volume in one second (FEV(1)) and the systemic inflammatory marker C-reactive protein (CRP) in young adults. METHODS: Associations between spirometric lung function and blood CRP were assessed in a population based birth cohort of approximately 1000 New Zealanders at ages 26 and 32 years. Analyses adjusted for height and sex to account for differences in predicted lung function and excluded pregnant women. RESULTS: There were significant inverse associations between FEV(1) and CRP at both ages. Similar results were found for the forced vital capacity. These associations were similar in men and women and were independent of smoking, asthma, and body mass index. CONCLUSIONS: Reduced lung function is associated with systemic inflammation in young adults. This association is not related to smoking, asthma, or obesity. The reasons for the association are unexplained, but the findings indicate that the association between lower lung function and increased inflammation predates the development of either chronic lung disease or clinically significant atherosclerosis. The association between poor lung function and cardiovascular disease may be mediated by an inflammatory mechanism.
Authors: Doron Aronson; Inon Roterman; Mordechay Yigla; Arthur Kerner; Ophir Avizohar; Ron Sella; Peter Bartha; Yishai Levy; Walter Markiewicz Journal: Am J Respir Crit Care Med Date: 2006-06-15 Impact factor: 21.405
Authors: J A Wedzicha; T A Seemungal; P K MacCallum; E A Paul; G C Donaldson; A Bhowmik; D J Jeffries; T W Meade Journal: Thromb Haemost Date: 2000-08 Impact factor: 5.249
Authors: J P de Torres; E Cordoba-Lanus; C López-Aguilar; M Muros de Fuentes; A Montejo de Garcini; A Aguirre-Jaime; B R Celli; C Casanova Journal: Eur Respir J Date: 2006-02-02 Impact factor: 16.671
Authors: M S Tockman; J D Pearson; J L Fleg; E J Metter; S Y Kao; K G Rampal; L J Cruise; J L Fozard Journal: Am J Respir Crit Care Med Date: 1995-02 Impact factor: 21.405
Authors: Bharat Thyagarajan; David R Jacobs; George G Apostol; Lewis J Smith; Cora E Lewis; O Dale Williams Journal: Int J Epidemiol Date: 2006-03-22 Impact factor: 7.196
Authors: A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro Journal: Br J Pharmacol Date: 2016-10-12 Impact factor: 8.739
Authors: Deepa Rastogi; Molly Jung; Garrett Strizich; Pamela A Shaw; Sonia M Davis; Oana L Klein; Frank J Penedo; Andrew L Ries; Martha L Daviglus; Juan J Moreiras; Matthias A Salathe; Juan C Celedón; Carmen R Isasi; Robert C Kaplan Journal: Respir Med Date: 2017-03-06 Impact factor: 3.415
Authors: Ravi Kalhan; Betty T Tran; Laura A Colangelo; Sharon R Rosenberg; Kiang Liu; Bharat Thyagarajan; David R Jacobs; Lewis J Smith Journal: PLoS One Date: 2010-07-02 Impact factor: 3.240